Phase Ii Study Of Cabozantinib (Cabo) In Patients (Pts) With Recurrent/Metastatic Endometrial Cancer (Ec): A Study Of The Princess Margaret, Chicago, And California Phase Ii Consortia.

JOURNAL OF CLINICAL ONCOLOGY(2017)

引用 3|浏览53
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要